Verve Therapeutics Inc. (VERV)
7.39
-0.37 (-4.77%)
At close: Jan 28, 2025, 2:57 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -4.47 | -6.64 | -15.08 | -33.79 | -80.92 |
| PS Ratio | 76.08 | 538.57 | n/a | n/a | n/a |
| PB Ratio | 1.49 | 1.90 | 5.01 | -24.08 | -78.71 |
| P/FCF Ratio | -5.63 | -7.71 | -21.75 | -39.78 | -165.51 |
| P/OCF Ratio | -5.98 | -8.55 | -22.97 | -43.64 | -206.81 |
| OCF/S Ratio | -12.72 | -63.03 | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.12 | 0.15 | 0.01 | -1.96 | -1.79 |
| Quick Ratio | 17.24 | 16.05 | 16.67 | 10.11 | 5.36 |
| Current Ratio | 17.24 | 16.05 | 16.67 | 10.11 | 5.36 |
| Asset Turnover | 0.02 | 0.00 | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.33 | -0.29 | -0.33 | 0.71 | 0.97 |
| Return on Assets (ROA) | -0.27 | -0.23 | -0.31 | -0.58 | -0.88 |
| Return on Capital (ROIC) | -0.31 | -0.26 | -0.24 | -0.57 | -0.75 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 53.61% | -245.75% | n/a | n/a | n/a |
| Net Profit Margin | -1.70K% | -8.11K% | n/a | n/a | n/a |
| Pretax Profit Margin | -1.70K% | -8.11K% | n/a | n/a | n/a |
| Operating Profit Margin | -1.90K% | -8.54K% | n/a | n/a | n/a |
| FCF Margin | -1.35K% | -6.98K% | n/a | n/a | n/a |
| EBITDA Margin | -1.85K% | -8.39K% | n/a | n/a | n/a |